From: Multidimensional prognostic indices for use in COPD patient care. A systematic review
COMPONENT | PREDICTOR | N |
---|---|---|
Physiologic | - Obstruction (FEV 1 as % from predicted) | 14 |
 | - Blood oxygen (PaO2) | 1 |
 | - Exercise maximum oxygen consumption | 1 |
Biomarkers | - Interleukin-6 | 1 |
Physical | - BMI (length/weight2) | 7 |
 | - Exercise tolerance (6MWD) | 4 |
 | - Knee extensor strength | 1 |
Medical history | - COPD duration | 1 |
 | - (Rate of) exacerbation (unscheduled visits, emergency department visits, hospitalisation, intubation) | 8 |
 | - History of cardiovascular disease | 2 |
Demographics | - Age | 5 |
 | - Gender | 1 |
 | - Smoking status | 1 |
 | - Influenza vaccination status | 1 |
Signs & symptoms | - Dyspnoea (ATS, MRC score, GCRQ, and Fletcher) | 9 |
 | - Quality of life (SGRQ) | 2 |
 | - Health status (CRQ and ad hoc questionnaires) | 2 |
 | - Respiratory symptoms like cough | 2 |
Treatment | - COPD medication (including steroids and theophylline) | 3 |
 | - Antibiotics | 1 |
 | - Home oxygen | 1 |